Blue Jet Healthcare declares Re 1.20 dividend per share for FY26

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Blue Jet Healthcare declared a dividend of Re 1.20 per share for FY26
  • Shareholders adopted audited financial statements for the year ended March 31, 2026
  • Directors Naresh Shah, Akshay Arora, and Shiven Arora were re-appointed
  • M/s. KKC & Associates LLP retained as statutory auditors
powered bylight_fuzz_icon
51525526

*this image is generated using AI for illustrative purposes only.

Blue Jet Healthcare declared a dividend of Re 1.20 per equity share for FY26 during its 58th annual general meeting. The event took place on September 21, 2026, via video conferencing.

The meeting commenced at 11:00 am with Chairman Akshay Bansarilal Arora presiding. Shareholders approved the adoption of audited standalone financial statements for the year ended March 31, 2026. The auditors' report contained no qualifications or adverse remarks.

Key Resolutions

Members passed ordinary resolutions to re-appoint Mr. Naresh Suryakant Shah as a director retiring by rotation. The company also re-appointed M/s. KKC & Associates LLP as statutory auditors.

Special resolutions secured approval for the re-appointment of Akshay Bansarilal Arora as whole-time director and executive chairman, alongside Shiven A. Arora as managing director.

Voting Process

Remote e-voting was facilitated by MUFG Intime India Private Limited from September 18 to September 20, 2026. Ms. Nupur Gadekar served as the scrutinizer for the e-voting process. The AGM concluded at 11:44 am.

Historical Stock Returns for Blue Jet Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.02%+2.21%-4.31%+51.60%-14.96%+40.57%

How does the Re 1.20 dividend per share compare to Blue Jet Healthcare's historical payout ratios and peer averages in the healthcare sector?

What strategic initiatives or capital allocation plans has management outlined to sustain growth following the re-appointment of key leadership figures?

Given the clean audit report, are there any specific operational metrics or revenue streams highlighted in the FY26 standalone financials that drove performance?

Blue Jet Healthcare sets Sept 21 AGM for dividend, board reappointments

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Blue Jet Healthcare Limited is holding its 58th AGM on September 21, 2026, via video conference. Key agenda items include approving a ₹1.20 per share final dividend for FY26, adopting financial statements, and reappointing Executive Chairman Akshay Bansarilal Arora and Managing Director Shiven A. Arora for five-year terms starting April 2027. Remote e-voting opens on September 18, 2026.

powered bylight_fuzz_icon
48589189

*this image is generated using AI for illustrative purposes only.

Blue Jet Healthcare has scheduled its 58th Annual General Meeting (AGM) for Monday, September 21, 2026, at 11:00 am IST. The meeting will be conducted through Video Conferencing or Other Audio Visual Means in compliance with Ministry of Corporate Affairs circulars. The primary agenda includes the adoption of audited standalone financial statements for the financial year ended March 31, 2026, and the approval of key management appointments.

The Board of Directors recommended a final dividend of ₹1.20 per equity share (face value ₹2 each) for FY26 during its meeting on May 25, 2026. The record date for determining dividend entitlement is set for Monday, September 14, 2026. Shareholders holding securities as on this cut-off date are eligible to participate in remote e-voting, which commences on Friday, September 18, 2026, at 9:00 am and concludes on Sunday, September 20, 2026, at 5:00 pm.

Key Agenda Items

The AGM notice outlines several critical resolutions requiring shareholder approval:

  • Adoption of Financials: Members will receive, consider, and adopt the Audited Standalone Financial Statements for FY26, along with reports from the Board and Auditors.
  • Director Re-appointment: Mr. Naresh Suryakant Shah is proposed for re-appointment as a Whole-Time Director, retiring by rotation.
  • Auditor Re-appointment: M/s. KKC & Associates LLP is proposed for re-appointment as Statutory Auditors for a second term of five years, extending until the conclusion of the 63rd AGM in FY31.

Executive Leadership Renewal

A significant portion of the agenda involves the re-appointment of the company’s top leadership for five-year terms effective from April 13, 2027, to April 12, 2032. Both appointments require approval via Special Resolution.

Executive Designation Term Details Remuneration Structure
Akshay Bansarilal Arora Executive Chairman Liable to retire by rotation Basic: ₹20 lakh/month + HRA: ₹10 lakh/month + Performance Linked Incentive
Shiven A. Arora Managing Director Not liable to retire by rotation Basic: ₹25.5 lakh/month + HRA: ₹18 lakh/month + Performance Linked Incentive

The remuneration packages include basic salaries, house rent allowances, performance-linked incentives, medical benefits, and other statutory contributions. The Board has sought member consent to pay remuneration exceeding limits prescribed under Regulation 17(6)(e) of the SEBI Listing Regulations, if applicable during their tenure.

Voting and Participation Guidelines

Shareholders can cast votes electronically through the MUFG Intime India Private Limited platform. Those holding shares in demat mode may use NSDL or CDSL login methods, while physical shareholders must register via InstaVote. Corporate members are required to submit certified board resolutions authorizing representatives to vote.

Ms. Nupur Gadekar, Partner at M/s. Mehta & Mehta Associates, has been appointed as the scrutinizer for the remote e-voting process, with Ms. Alifiya Sapatwala as the alternate. The Company Secretary, Sweta Poddar, confirmed that the Annual Report and AGM Notice were dispatched electronically on August 18, 2026. Shareholders are advised to update their KYC details with depositories to ensure timely receipt of dividends, which will be paid within thirty days of AGM approval.

Historical Stock Returns for Blue Jet Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.02%+2.21%-4.31%+51.60%-14.96%+40.57%

How might the substantial remuneration packages for Executive Chairman Akshay Arora and MD Shiven Arora impact shareholder sentiment and voting outcomes at the AGM?

What specific performance metrics will drive the 'Performance Linked Incentives' for top executives, and how do these align with Blue Jet Healthcare's long-term growth strategy?

Given the re-appointment of KKC & Associates LLP for a five-year term, are there any emerging audit risks or regulatory concerns that shareholders should monitor over the next few years?

More News on Blue Jet Healthcare

1 Year Returns:-14.96%